| Characteristics . | Rhinovirus Only . | Rhinovirus Codetection . | Other Respiratory Virusesb . | No Respiratory Virus Detectedc . |
|---|---|---|---|---|
| No. of unique participants | 647 | 66 | 408 | 2996 |
| Age, y | ||||
| Overall, median (range) | 29 (0.3–85) | 22 (0.4–83) | 36 (0.3–81) | 37 (0.3–85) |
| <5 | 72 (11.1) | 21 (31.8) | 43 (10.5) | 154 (5.1) |
| 5–11 | 71 (11.0) | 7 (10.6) | 36 (8.8) | 189 (6.3) |
| 12–17 | 33 (5.1) | 1 (1.5) | 16 (3.9) | 101 (3.4) |
| 18–49 | 321 (49.6) | 21 (31.8) | 193 (47.3) | 1635 (54.6) |
| 50–64 | 131 (20.3) | 11 (16.7) | 99 (24.3) | 752 (25.1) |
| ≥65 | 19 (2.9) | 5 (7.6) | 21 (5.2) | 164 (5.5) |
| Sex | ||||
| Male | 372 (57.5) | 43 (65.2) | 245 (59.8) | 1815 (60.6) |
| Female | 265 (41.0) | 21 (31.8) | 161 (39.3) | 1127 (37.6) |
| Other | 2 (0.3) | 1 (1.5) | 0 | 16 (0.5) |
| Prefer not to say | 8 (1.2) | 1 (1.5) | 4 (1.0) | 38 (1.3) |
| Race | ||||
| White | 268 (41.4) | 28 (42.4) | 167 (40.7) | 1208 (40.3) |
| Black | 206 (31.8) | 15 (22.7) | 150 (36.6) | 950 (31.7) |
| Asian | 12 (1.9) | 1 (1.5) | 4 (1.0) | 114 (3.8) |
| American Indian or Alaskan Native | 15 (2.3) | 3 (4.6) | 16 (3.9) | 121 (4.0) |
| Native Hawaiian or Pacific Islander | 50 (7.7) | 8 (12.1) | 18 (4.4) | 129 (4.3) |
| Other | 32 (5.0) | 3 (4.6) | 35 (8.5) | 263 (8.8) |
| Prefer not to say | 64 (9.9) | 8 (12.1) | 20 (4.9) | 211 (7.0) |
| Ethnicity | ||||
| Hispanic | 105 (16.2) | 15 (22.7) | 58 (14.2) | 440 (14.7) |
| Non-Hispanic | 527 (815) | 50 (75.8) | 345 (84.2) | 2502 (83.5) |
| Unknown | 15 (2.3) | 1 (1.5) | 7 (1.6) | 54 (1.8) |
| Pregnancy status among women of child-bearing age | n = 179 | n = 7 | n = 100 | n = 770 |
| Pregnant | 2 (1.1) | 0 | 4 (4.0) | 13 (1.7) |
| Not pregnant | 38 (21.2) | 2 (28.6) | 41 (41.0) | 128 (16.6) |
| Prefer not to say | 139 (77.7) | 5 (71.4) | 55 (55.0) | 629 (81.7) |
| Smoking status | ||||
| Current tobacco use | 263 (40.7) | 20 (30.3) | 170 (41.5) | 1368 (45.7) |
| E-cigarette use/vape | 51 (19.4) | 5 (25.0) | 20 (11.8) | 210 (15.4) |
| Underlying medical conditions | ||||
| None | 475 (73.4) | 51 (77.3) | 291 (71.0) | 2081 (69.5) |
| At least 1 underlying medical condition | 172 (26.6) | 15 (22.7) | 119 (29.0) | 915 (30.5) |
| Neurological disease | 12 (2.2) | 0 | 13 (3.6) | 63 (2.6) |
| Cardiovascular disease | 13 (2.0) | 2 (3.0) | 12 (2.9) | 95 (3.2) |
| Asthma | 76 (11.8) | 8 (12.1) | 43 (10.5) | 393 (13.1) |
| Bronchitis | 16 (2.5) | 0 | 13 (3.2) | 93 (3.1) |
| COPD | 30 (4.6) | 1 (1.5) | 11 (2.7) | 116 (3.9) |
| Hepatic disease | 12 (1.9) | 1 (1.5) | 9 (2.2) | 85 (2.8) |
| Diabetes mellitus | 35 (5.4) | 5 (7.6) | 37 (9.0) | 199 (6.6) |
| Immunosuppression | 7 (1.1) | 1 (1.5) | 8 (2.0) | 36 (1.2) |
| Cancer | 12 (1.9) | 0 | 8 (2.0) | 57 (1.9) |
| Other | 7 (1.1) | 0 | 4 (1.0) | 31 (1.0) |
| Shelter staff | 78 (12.1) | 6 (9.1) | 34 (8.3) | 50 (18.4) |
| Number of encounters | 986 | 80 | 503 | 12 895 |
| Characteristics . | Rhinovirus Only . | Rhinovirus Codetection . | Other Respiratory Virusesb . | No Respiratory Virus Detectedc . |
|---|---|---|---|---|
| No. of unique participants | 647 | 66 | 408 | 2996 |
| Age, y | ||||
| Overall, median (range) | 29 (0.3–85) | 22 (0.4–83) | 36 (0.3–81) | 37 (0.3–85) |
| <5 | 72 (11.1) | 21 (31.8) | 43 (10.5) | 154 (5.1) |
| 5–11 | 71 (11.0) | 7 (10.6) | 36 (8.8) | 189 (6.3) |
| 12–17 | 33 (5.1) | 1 (1.5) | 16 (3.9) | 101 (3.4) |
| 18–49 | 321 (49.6) | 21 (31.8) | 193 (47.3) | 1635 (54.6) |
| 50–64 | 131 (20.3) | 11 (16.7) | 99 (24.3) | 752 (25.1) |
| ≥65 | 19 (2.9) | 5 (7.6) | 21 (5.2) | 164 (5.5) |
| Sex | ||||
| Male | 372 (57.5) | 43 (65.2) | 245 (59.8) | 1815 (60.6) |
| Female | 265 (41.0) | 21 (31.8) | 161 (39.3) | 1127 (37.6) |
| Other | 2 (0.3) | 1 (1.5) | 0 | 16 (0.5) |
| Prefer not to say | 8 (1.2) | 1 (1.5) | 4 (1.0) | 38 (1.3) |
| Race | ||||
| White | 268 (41.4) | 28 (42.4) | 167 (40.7) | 1208 (40.3) |
| Black | 206 (31.8) | 15 (22.7) | 150 (36.6) | 950 (31.7) |
| Asian | 12 (1.9) | 1 (1.5) | 4 (1.0) | 114 (3.8) |
| American Indian or Alaskan Native | 15 (2.3) | 3 (4.6) | 16 (3.9) | 121 (4.0) |
| Native Hawaiian or Pacific Islander | 50 (7.7) | 8 (12.1) | 18 (4.4) | 129 (4.3) |
| Other | 32 (5.0) | 3 (4.6) | 35 (8.5) | 263 (8.8) |
| Prefer not to say | 64 (9.9) | 8 (12.1) | 20 (4.9) | 211 (7.0) |
| Ethnicity | ||||
| Hispanic | 105 (16.2) | 15 (22.7) | 58 (14.2) | 440 (14.7) |
| Non-Hispanic | 527 (815) | 50 (75.8) | 345 (84.2) | 2502 (83.5) |
| Unknown | 15 (2.3) | 1 (1.5) | 7 (1.6) | 54 (1.8) |
| Pregnancy status among women of child-bearing age | n = 179 | n = 7 | n = 100 | n = 770 |
| Pregnant | 2 (1.1) | 0 | 4 (4.0) | 13 (1.7) |
| Not pregnant | 38 (21.2) | 2 (28.6) | 41 (41.0) | 128 (16.6) |
| Prefer not to say | 139 (77.7) | 5 (71.4) | 55 (55.0) | 629 (81.7) |
| Smoking status | ||||
| Current tobacco use | 263 (40.7) | 20 (30.3) | 170 (41.5) | 1368 (45.7) |
| E-cigarette use/vape | 51 (19.4) | 5 (25.0) | 20 (11.8) | 210 (15.4) |
| Underlying medical conditions | ||||
| None | 475 (73.4) | 51 (77.3) | 291 (71.0) | 2081 (69.5) |
| At least 1 underlying medical condition | 172 (26.6) | 15 (22.7) | 119 (29.0) | 915 (30.5) |
| Neurological disease | 12 (2.2) | 0 | 13 (3.6) | 63 (2.6) |
| Cardiovascular disease | 13 (2.0) | 2 (3.0) | 12 (2.9) | 95 (3.2) |
| Asthma | 76 (11.8) | 8 (12.1) | 43 (10.5) | 393 (13.1) |
| Bronchitis | 16 (2.5) | 0 | 13 (3.2) | 93 (3.1) |
| COPD | 30 (4.6) | 1 (1.5) | 11 (2.7) | 116 (3.9) |
| Hepatic disease | 12 (1.9) | 1 (1.5) | 9 (2.2) | 85 (2.8) |
| Diabetes mellitus | 35 (5.4) | 5 (7.6) | 37 (9.0) | 199 (6.6) |
| Immunosuppression | 7 (1.1) | 1 (1.5) | 8 (2.0) | 36 (1.2) |
| Cancer | 12 (1.9) | 0 | 8 (2.0) | 57 (1.9) |
| Other | 7 (1.1) | 0 | 4 (1.0) | 31 (1.0) |
| Shelter staff | 78 (12.1) | 6 (9.1) | 34 (8.3) | 50 (18.4) |
| Number of encounters | 986 | 80 | 503 | 12 895 |
Abbreviations: COPD, chronic obstructive pulmonary disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Categories are not mutually exclusive as participants may have had more than 1 encounter with different results.
There were n = 22 encounters where an inconclusive SARS-CoV-2 test was recategorized as a negative result; of note, there were no other pathogens detected in these samples and n = 17 of these samples came from asymptomatic participants; n = 2 encounters where participant age is missing and were not included in the age analysis.
n = 1 encounter where participant age is missing and was not included in the age analysis.
| Characteristics . | Rhinovirus Only . | Rhinovirus Codetection . | Other Respiratory Virusesb . | No Respiratory Virus Detectedc . |
|---|---|---|---|---|
| No. of unique participants | 647 | 66 | 408 | 2996 |
| Age, y | ||||
| Overall, median (range) | 29 (0.3–85) | 22 (0.4–83) | 36 (0.3–81) | 37 (0.3–85) |
| <5 | 72 (11.1) | 21 (31.8) | 43 (10.5) | 154 (5.1) |
| 5–11 | 71 (11.0) | 7 (10.6) | 36 (8.8) | 189 (6.3) |
| 12–17 | 33 (5.1) | 1 (1.5) | 16 (3.9) | 101 (3.4) |
| 18–49 | 321 (49.6) | 21 (31.8) | 193 (47.3) | 1635 (54.6) |
| 50–64 | 131 (20.3) | 11 (16.7) | 99 (24.3) | 752 (25.1) |
| ≥65 | 19 (2.9) | 5 (7.6) | 21 (5.2) | 164 (5.5) |
| Sex | ||||
| Male | 372 (57.5) | 43 (65.2) | 245 (59.8) | 1815 (60.6) |
| Female | 265 (41.0) | 21 (31.8) | 161 (39.3) | 1127 (37.6) |
| Other | 2 (0.3) | 1 (1.5) | 0 | 16 (0.5) |
| Prefer not to say | 8 (1.2) | 1 (1.5) | 4 (1.0) | 38 (1.3) |
| Race | ||||
| White | 268 (41.4) | 28 (42.4) | 167 (40.7) | 1208 (40.3) |
| Black | 206 (31.8) | 15 (22.7) | 150 (36.6) | 950 (31.7) |
| Asian | 12 (1.9) | 1 (1.5) | 4 (1.0) | 114 (3.8) |
| American Indian or Alaskan Native | 15 (2.3) | 3 (4.6) | 16 (3.9) | 121 (4.0) |
| Native Hawaiian or Pacific Islander | 50 (7.7) | 8 (12.1) | 18 (4.4) | 129 (4.3) |
| Other | 32 (5.0) | 3 (4.6) | 35 (8.5) | 263 (8.8) |
| Prefer not to say | 64 (9.9) | 8 (12.1) | 20 (4.9) | 211 (7.0) |
| Ethnicity | ||||
| Hispanic | 105 (16.2) | 15 (22.7) | 58 (14.2) | 440 (14.7) |
| Non-Hispanic | 527 (815) | 50 (75.8) | 345 (84.2) | 2502 (83.5) |
| Unknown | 15 (2.3) | 1 (1.5) | 7 (1.6) | 54 (1.8) |
| Pregnancy status among women of child-bearing age | n = 179 | n = 7 | n = 100 | n = 770 |
| Pregnant | 2 (1.1) | 0 | 4 (4.0) | 13 (1.7) |
| Not pregnant | 38 (21.2) | 2 (28.6) | 41 (41.0) | 128 (16.6) |
| Prefer not to say | 139 (77.7) | 5 (71.4) | 55 (55.0) | 629 (81.7) |
| Smoking status | ||||
| Current tobacco use | 263 (40.7) | 20 (30.3) | 170 (41.5) | 1368 (45.7) |
| E-cigarette use/vape | 51 (19.4) | 5 (25.0) | 20 (11.8) | 210 (15.4) |
| Underlying medical conditions | ||||
| None | 475 (73.4) | 51 (77.3) | 291 (71.0) | 2081 (69.5) |
| At least 1 underlying medical condition | 172 (26.6) | 15 (22.7) | 119 (29.0) | 915 (30.5) |
| Neurological disease | 12 (2.2) | 0 | 13 (3.6) | 63 (2.6) |
| Cardiovascular disease | 13 (2.0) | 2 (3.0) | 12 (2.9) | 95 (3.2) |
| Asthma | 76 (11.8) | 8 (12.1) | 43 (10.5) | 393 (13.1) |
| Bronchitis | 16 (2.5) | 0 | 13 (3.2) | 93 (3.1) |
| COPD | 30 (4.6) | 1 (1.5) | 11 (2.7) | 116 (3.9) |
| Hepatic disease | 12 (1.9) | 1 (1.5) | 9 (2.2) | 85 (2.8) |
| Diabetes mellitus | 35 (5.4) | 5 (7.6) | 37 (9.0) | 199 (6.6) |
| Immunosuppression | 7 (1.1) | 1 (1.5) | 8 (2.0) | 36 (1.2) |
| Cancer | 12 (1.9) | 0 | 8 (2.0) | 57 (1.9) |
| Other | 7 (1.1) | 0 | 4 (1.0) | 31 (1.0) |
| Shelter staff | 78 (12.1) | 6 (9.1) | 34 (8.3) | 50 (18.4) |
| Number of encounters | 986 | 80 | 503 | 12 895 |
| Characteristics . | Rhinovirus Only . | Rhinovirus Codetection . | Other Respiratory Virusesb . | No Respiratory Virus Detectedc . |
|---|---|---|---|---|
| No. of unique participants | 647 | 66 | 408 | 2996 |
| Age, y | ||||
| Overall, median (range) | 29 (0.3–85) | 22 (0.4–83) | 36 (0.3–81) | 37 (0.3–85) |
| <5 | 72 (11.1) | 21 (31.8) | 43 (10.5) | 154 (5.1) |
| 5–11 | 71 (11.0) | 7 (10.6) | 36 (8.8) | 189 (6.3) |
| 12–17 | 33 (5.1) | 1 (1.5) | 16 (3.9) | 101 (3.4) |
| 18–49 | 321 (49.6) | 21 (31.8) | 193 (47.3) | 1635 (54.6) |
| 50–64 | 131 (20.3) | 11 (16.7) | 99 (24.3) | 752 (25.1) |
| ≥65 | 19 (2.9) | 5 (7.6) | 21 (5.2) | 164 (5.5) |
| Sex | ||||
| Male | 372 (57.5) | 43 (65.2) | 245 (59.8) | 1815 (60.6) |
| Female | 265 (41.0) | 21 (31.8) | 161 (39.3) | 1127 (37.6) |
| Other | 2 (0.3) | 1 (1.5) | 0 | 16 (0.5) |
| Prefer not to say | 8 (1.2) | 1 (1.5) | 4 (1.0) | 38 (1.3) |
| Race | ||||
| White | 268 (41.4) | 28 (42.4) | 167 (40.7) | 1208 (40.3) |
| Black | 206 (31.8) | 15 (22.7) | 150 (36.6) | 950 (31.7) |
| Asian | 12 (1.9) | 1 (1.5) | 4 (1.0) | 114 (3.8) |
| American Indian or Alaskan Native | 15 (2.3) | 3 (4.6) | 16 (3.9) | 121 (4.0) |
| Native Hawaiian or Pacific Islander | 50 (7.7) | 8 (12.1) | 18 (4.4) | 129 (4.3) |
| Other | 32 (5.0) | 3 (4.6) | 35 (8.5) | 263 (8.8) |
| Prefer not to say | 64 (9.9) | 8 (12.1) | 20 (4.9) | 211 (7.0) |
| Ethnicity | ||||
| Hispanic | 105 (16.2) | 15 (22.7) | 58 (14.2) | 440 (14.7) |
| Non-Hispanic | 527 (815) | 50 (75.8) | 345 (84.2) | 2502 (83.5) |
| Unknown | 15 (2.3) | 1 (1.5) | 7 (1.6) | 54 (1.8) |
| Pregnancy status among women of child-bearing age | n = 179 | n = 7 | n = 100 | n = 770 |
| Pregnant | 2 (1.1) | 0 | 4 (4.0) | 13 (1.7) |
| Not pregnant | 38 (21.2) | 2 (28.6) | 41 (41.0) | 128 (16.6) |
| Prefer not to say | 139 (77.7) | 5 (71.4) | 55 (55.0) | 629 (81.7) |
| Smoking status | ||||
| Current tobacco use | 263 (40.7) | 20 (30.3) | 170 (41.5) | 1368 (45.7) |
| E-cigarette use/vape | 51 (19.4) | 5 (25.0) | 20 (11.8) | 210 (15.4) |
| Underlying medical conditions | ||||
| None | 475 (73.4) | 51 (77.3) | 291 (71.0) | 2081 (69.5) |
| At least 1 underlying medical condition | 172 (26.6) | 15 (22.7) | 119 (29.0) | 915 (30.5) |
| Neurological disease | 12 (2.2) | 0 | 13 (3.6) | 63 (2.6) |
| Cardiovascular disease | 13 (2.0) | 2 (3.0) | 12 (2.9) | 95 (3.2) |
| Asthma | 76 (11.8) | 8 (12.1) | 43 (10.5) | 393 (13.1) |
| Bronchitis | 16 (2.5) | 0 | 13 (3.2) | 93 (3.1) |
| COPD | 30 (4.6) | 1 (1.5) | 11 (2.7) | 116 (3.9) |
| Hepatic disease | 12 (1.9) | 1 (1.5) | 9 (2.2) | 85 (2.8) |
| Diabetes mellitus | 35 (5.4) | 5 (7.6) | 37 (9.0) | 199 (6.6) |
| Immunosuppression | 7 (1.1) | 1 (1.5) | 8 (2.0) | 36 (1.2) |
| Cancer | 12 (1.9) | 0 | 8 (2.0) | 57 (1.9) |
| Other | 7 (1.1) | 0 | 4 (1.0) | 31 (1.0) |
| Shelter staff | 78 (12.1) | 6 (9.1) | 34 (8.3) | 50 (18.4) |
| Number of encounters | 986 | 80 | 503 | 12 895 |
Abbreviations: COPD, chronic obstructive pulmonary disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Categories are not mutually exclusive as participants may have had more than 1 encounter with different results.
There were n = 22 encounters where an inconclusive SARS-CoV-2 test was recategorized as a negative result; of note, there were no other pathogens detected in these samples and n = 17 of these samples came from asymptomatic participants; n = 2 encounters where participant age is missing and were not included in the age analysis.
n = 1 encounter where participant age is missing and was not included in the age analysis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
